InsiderSignal.AI

InsiderSignal.ai

LBRX - Lb Pharmaceuticals Inc

Insider Purchase by Vida Ventures Gp Iii, L.L.C. (10%)

6 Months
After Trade
Before Trade

Loading data...

Trade Summary

5 months ago, Vida Ventures Gp Iii, L.L.C., serving as 10% owner at Lb Pharmaceuticals Inc (LBRX), purchased 333,333 shares at $15.00 per share, for a total transaction value of $4,999,995.00. Following this transaction, Vida Ventures Gp Iii, L.L.C. now holds 883,677 shares of LBRX.

This purchase represents a 61.00% increase in Vida Ventures Gp Iii, L.L.C.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, September 12, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, September 16, 2025, 4 days after the trade was made.

Lb Pharmaceuticals Inc operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Vida Ventures Gp Iii, L.L.C.

10%

Vida Ventures GP III, L.L.C. is the general partner of Vida Ventures III, a Delaware limited liability company acting as a corporate insider in biomedical investments.[[2]](https://www.sec.gov/Archives/edgar/data/1724489/000095017024015479/xslF345X05/ownership.xml)[[5]](https://www.sec.gov/Archives/edgar/data/1724489/000199937124005643/vida-sc13d_021224.htm) It recently engaged in trading representing 10% ownership at LB Pharmaceuticals Inc (LBRX), reflecting its role in managing stakes for its affiliated venture capital fund.[user query] Vida Ventures, founded in 2017, is a Los Angeles- and Boston-based venture capital firm specializing in early-stage investments in biomedical companies across the United States, with a mission to transform innovations into therapies for patients.[[3]](https://www.privateequityinternational.com/institution-profiles/vida-ventures.html)[[4]](https://vidaventures.com) The firm manages multiple closed funds and is led by experienced leaders including Co-Founders Arie Belldegrun (Senior Managing Director), Arjun Goyal (Managing Director), and others like Brian Goodman (Managing Director), with a team boasting backgrounds in founding successful biotechs such as Kite Pharma (acquired by Gilead) and Allogene Therapeutics.[[1]](https://vidaventures.com/vida-team/)[[3]](https://www.privateequityinternational.com/institution-profiles/vida-ventures.html)[[4]](https://vidaventures.com)

View full insider profile →

Trade Price

$15.00

Quantity

333,333

Total Value

$4,999,995.00

Shares Owned

883,677

Trade Date

Friday, September 12, 2025

163 days ago

SEC Filing Date

Tuesday, September 16, 2025

Filed 4 days after trade

NONENONE

About Lb Pharmaceuticals Inc

Company Overview

No company information available
View news mentioning LBRX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/362220

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime